Loading...
Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site
The serine/threonine kinase, GSK-3, is a promising drug discovery target for treating multiple pathological disorders. Most GSK-3 inhibitors that were developed function as ATP competitive inhibitors, with typical limitations in specificity, safety and drug-induced resistance. In contrast, substrate...
Saved in:
| Published in: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7698860/ https://ncbi.nlm.nih.gov/pubmed/33218072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21228709 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|